Physician Assistant · Potsdam, NY
NPI
1831262567
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
49 Lawrence Ave
Potsdam, NY, 13676
Phone (315) 265-6800
Groups this clinician bills Medicare through
Medicare paid, 2024
$101K
4,149 services
Medicare patients, 2024
1,161
Average age 75
Drug cost, 2024
$4.1M
2,320 prescriptions
Company payments, 2025
$910
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank Bateman was code 17003 (destruction skin lesion), 1,619 times for 430 patients. In total Frank Bateman billed 4,149 services in 30 codes, and Medicare paid $101K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,619 | 430 | $1.26 | $2,037 |
| 99213 Office E&M - Established | Office | 1,079 | 858 | $38.90 | $42K |
| 17000 Destruction Skin Lesion | Office | 703 | 594 | $31.02 | $22K |
| 99214 Office E&M - Established | Office | 395 | 369 | $48.23 | $19K |
| 11102 Skin Biopsy | Office | 70 | 68 | $19.16 | $1,341 |
| 17110 Destruction Skin Lesion | Office | 52 | 51 | $36.72 | $1,909 |
| 99203 Office E&M - New | Office | 40 | 40 | $46.58 | $1,863 |
| 17262 Destruction Skin Lesion | Office | 39 | 25 | $61.48 | $2,398 |
| 17281 Destruction Skin Lesion | Office | 25 | 23 | $68.99 | $1,725 |
| 99204 Office E&M - New | Office | 24 | 24 | $68.39 | $1,641 |
| 11200 Removal or Shaving of Skin Growth | Office | 20 | 20 | $50.64 | $1,013 |
| 17261 Destruction Skin Lesion | Office | 16 | 15 | $42.10 | $674 |
| 17282 Destruction Skin Lesion | Office | 15 | 15 | $79.02 | $1,185 |
By year: 2022 $83K for 3,720 services; 2023 $91K for 3,875 services; 2024 $101K for 4,149 services.
Medicare prescription drug claims, 2024
In 2024, the drug Frank Bateman prescribed most often to Medicare patients was Ketoconazole, with 180 prescriptions and refills. In total Frank Bateman wrote 2,320 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 180 | 197 | 46 | $3,376 |
| Clobetasol Propionate Generic | 168 | 185 | 85 | $9,197 |
| Triamcinolone Acetonide Generic | 131 | 160 | 62 | $1,345 |
| Ammonium Lactate Generic | 127 | 172 | 62 | $2,861 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 96 | 107 | 50 | $5,057 |
| Dupixent Syringe Dupilumab | 89 | 110 | 13 | $405K |
| Fluocinonide Generic | 86 | 91 | 43 | $4,212 |
| Dupixent Pen Dupilumab | 78 | 85 | 16 | $322K |
| Hydrocortisone Generic | 60 | 73 | 41 | $777 |
| Minocycline Hcl Generic | 58 | 80 | 20 | $1,785 |
| Fluticasone Propionate Generic | 57 | 68 | 40 | $1,905 |
| Otezla Apremilast | 54 | 74 | Under 11 | $325K |
| Doxycycline Hyclate Generic | 51 | 103 | 18 | $1,874 |
| Humira(Cf) Pen Adalimumab | 50 | 50 | Under 11 | $414K |
| Tremfya Guselkumab | 50 | 93 | 11 | $665K |
Brand drugs: 497 claims; generic drugs: 1,823 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank Bateman $910 ($910 in general payments such as food, travel and fees) from 10 companies. The largest payer was Janssen Biotech, Inc. with $332.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 24 | $332 |
| Pfizer Inc. PFE | 9 | $171 |
| Lilly USA, LLC LLY | 3 | $63.98 |
| LEO Pharma Inc. | 3 | $58.44 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $58.3 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $57.15 |
| Abbvie Inc. ABBV | 3 | $54.41 |
| UCB, Inc. UCB.BR | 2 | $51.38 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $38.48 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $24.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.